MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -15.9% | 3,814 | +4.4% | 0.00% | – |
| Q2 2023 | $44 | -66.2% | 3,655 | -60.9% | 0.00% | – |
| Q1 2023 | $130 | +176.6% | 9,350 | +181.4% | 0.00% | – |
| Q4 2022 | $47 | -95.3% | 3,323 | +8207.5% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 40 | -60.4% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 101 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -76.9% | 101 | -67.6% | 0.00% | – |
| Q4 2021 | $13,000 | -99.9% | 312 | -99.9% | 0.00% | -100.0% |
| Q3 2021 | $17,273,000 | -75.9% | 351,950 | -79.5% | 0.02% | -76.2% |
| Q2 2021 | $71,722,000 | -40.1% | 1,718,721 | -48.9% | 0.08% | -44.8% |
| Q1 2021 | $119,795,000 | +25.0% | 3,361,267 | -1.6% | 0.14% | +19.8% |
| Q4 2020 | $95,799,000 | – | 3,415,297 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |